Latest Market News

Universal Biosensors has requested a voluntary suspension of its shares on the ASX, pending details of a proposed capital raising. The suspension is expected to last until the end of June or until the announcement is made.

Vection Technologies has secured a $2.6 million contract to co-develop SAFE-XR, an AI-powered safety compliance platform using augmented reality and wearable tech for industrial inspections in Italy.

Amaero has completed commissioning its second advanced atomizer at its Tennessee facility, reinforcing its production capacity and reaffirming strong revenue visibility for FY2026. The company’s strategic investments position it as a key domestic supplier in the US advanced manufacturing sector.

GreenHy2 Limited has successfully raised nearly $1 million through a strategic share placement aimed at fast-tracking its innovative energy storage products, including hybridised graphene batteries and hydrogen solutions.

Ionic Rare Earths is advancing plans for multiple magnet recycling plants in the US, leveraging patented technology to produce high-purity rare earth oxides amid growing demand for sovereign supply chains.

BirdDog Technology has postponed its shareholder meeting to July 22, raising its share buy-back price by 40% to 7 cents ahead of a proposed ASX delisting. Major shareholders back the move, signaling strong support for the company’s exit plan.

Downer EDI Limited has successfully refinanced $1 billion of its syndicated sustainability linked loan facility, extending maturities and improving its debt maturity profile amid upcoming bond repayments.

X2M Connect has secured a $3 million deal to supply 100,000 IoT-connected personal safety devices for Seoul’s 2025 Smart City initiative, with potential to scale to one million units.

Rimfire Mining has unveiled compelling high-grade scandium assay results from its Currajong Prospect in NSW’s Fifield District, reinforcing its position as a significant scandium opportunity amid tightening global supply.

Enero Group has replaced its $50 million debt facility with a smaller $15 million revolving credit line from NAB, reflecting a strategic shift towards reduced capital needs and strong cash reserves.

Solis Minerals has intersected promising copper-gold mineralisation including visible gold at its Chancho al Palo prospect in Peru, with assays expected in July/August 2025. The initial drill hole confirms the presence of both IOCG and porphyry-style systems in a highly prospective region.

Optiscan Imaging Ltd has entered a five-year exclusive collaboration with Long Grove Pharmaceuticals to jointly develop new clinical applications for the fluorescein drug AK-FLOUR®, supporting US clinical trials and FDA regulatory submissions for Optiscan’s InVue® surgical device.